Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by CCAbbott888on Apr 29, 2019 12:07pm
172 Views
Post# 29683767

RE:RE:RE:RE:Three thoughts on the rights offer

RE:RE:RE:RE:Three thoughts on the rights offer
Yukon78 wrote: What can the AMF do and what is the probability?

Yukon78 Others who are more experienced may get back to you. 

My own past experience with IIROC for other stocks and the recent TMX decision (on April 23) to ok PLI's application to go ahead with the plan un-interrupted do not provide much for optimism.  However, one can be thankful that it's on Tuesday April 30, the uncertainty about AMF's decision will soon be cleared.  From the below, I think that even the most severe cases, e.g. 'result in sanctions', probably will not un-do what is already being done (i.e. refinancing), imo.  

This is what AMF web site said 
We examine all situations brought to our attention. In some cases, the information may be used to remind a firm of its obligations respecting sound commercial practices. In others, the AMF may exercise its investigative powers and then launch penal proceedings that could result in sanctions.
Bullboard Posts